Carol Karp
Conseiller Juridique Général chez PROTHENA CORPORATION PLC
Fortune : - $ au 31/05/2024
Postes actifs de Carol Karp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Conseiller Juridique Général | 15/12/2016 | - |
| Rochester Christian University | Directeur/Membre du Conseil | - | - |
Historique de carrière de Carol Karp
Anciens postes connus de Carol Karp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ESPERION THERAPEUTICS, INC. | Compliance Officer | 01/01/2013 | 01/01/2014 |
| Conseiller Juridique Général | 01/01/2013 | 01/01/2014 | |
| Janssen Alzheimer Immunotherapy | Conseiller Juridique Général | 01/01/2010 | 01/01/2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Conseiller Juridique Général | - | 02/05/2011 |
| VIVUS, INC. | Corporate Officer/Principal | - | - |
| Powderject Technologies BV | Directeur Technique/Scientifique/R&D | - | - |
Formation de Carol Karp
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Pays-Bas | 2 |
| Irlande | 2 |
Opérationnelle
| General Counsel | 4 |
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
| Janssen Alzheimer Immunotherapy |
- Bourse
- Insiders
- Carol Karp
- Expérience
